Literature DB >> 9020075

Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis.

C Giordano1, G Stassi, R De Maria, M Todaro, P Richiusa, G Papoff, G Ruberti, M Bagnasco, R Testi, A Galluzzo.   

Abstract

The mechanisms responsible for thyrocyte destruction in Hashimoto's thyroiditis (HT) are poorly understood. Thyrocytes from HT glands, but not from nonautoimmune thyroids, expressed Fas. Interleukin-1beta (IL-1beta), abundantly produced in HT glands, induced Fas expression in normal thyrocytes, and cross-linking of Fas resulted in massive thyrocyte apoptosis. The ligand for Fas (FasL) was shown to be constitutively expressed both in normal and HT thyrocytes and was able to kill Fas-sensitive targets. Exposure to IL-1beta induced thyrocyte apoptosis, which was prevented by antibodies that block Fas, suggesting that IL-1beta-induced Fas expression serves as a limiting factor for thyrocyte destruction. Thus, Fas-FasL interactions among HT thyrocytes may contribute to clinical hypothyroidism.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9020075     DOI: 10.1126/science.275.5302.960

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  89 in total

Review 1.  The role of apoptosis in the initiation of the autoimmune response in Sjögren's syndrome.

Authors:  M G Humphreys-Beher; A B Peck; H Dang; N Talal
Journal:  Clin Exp Immunol       Date:  1999-06       Impact factor: 4.330

2.  Severe destructive autoimmune lesions with aging in murine Sjögren's syndrome through Fas-mediated apoptosis.

Authors:  N Ishimaru; T Yoneda; K Saegusa; K Yanagi; N Haneji; K Moriyama; I Saito; Y Hayashi
Journal:  Am J Pathol       Date:  2000-05       Impact factor: 4.307

3.  Implication of interfering antibody formation and apoptosis as two different mechanisms leading to variable duration of adenovirus-mediated transgene expression in immune-competent mice.

Authors:  D B Schowalter; C L Himeda; B L Winther; C B Wilson; M A Kay
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

4.  No eczema without keratinocyte death.

Authors:  T Schwarz
Journal:  J Clin Invest       Date:  2000-07       Impact factor: 14.808

Review 5.  Expression patterns of cellular growth-controlling genes in non-medullary thyroid cancer: basic aspects.

Authors:  N J Sarlis
Journal:  Rev Endocr Metab Disord       Date:  2000-04       Impact factor: 6.514

6.  Thyroid autoimmunity.

Authors:  B Rapoport; S M McLachlan
Journal:  J Clin Invest       Date:  2001-11       Impact factor: 14.808

Review 7.  The role of apoptosis in autoimmune thyroid disorders and thyroid cancer.

Authors:  J D Lin
Journal:  BMJ       Date:  2001-06-23

8.  Thyroid autoimmune disease: demonstration of thyroid antigen-specific B cells and recombination-activating gene expression in chemokine-containing active intrathyroidal germinal centers.

Authors:  M P Armengol; M Juan; A Lucas-Martín; M T Fernández-Figueras; D Jaraquemada; T Gallart; R Pujol-Borrell
Journal:  Am J Pathol       Date:  2001-09       Impact factor: 4.307

9.  Fas-Fas ligand system as a possible mediator of spermatogenic cell apoptosis in human maturation-arrested testes.

Authors:  Jiro Eguchi; Takehiko Koji; Koichiro Nomata; Akira Yoshii; Masashi Shin; Hiroshi Kanetake
Journal:  Hum Cell       Date:  2002-03       Impact factor: 4.174

Review 10.  CD95 (Fas/APO-1)/CD95L in the gastrointestinal tract: fictions and facts.

Authors:  J Sträter; P Möller
Journal:  Virchows Arch       Date:  2003-02-11       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.